Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 295 participants.

Also called NCT03071263

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 295 participants (enrolled count) (from the registry)
Sponsor
  • Relypsa, Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03071263
  • EudraCT 2016-002657-38
Other papers using this trial's data
  • Patiromer and Spironolactone in Resistant Hypertension and Advanced CKD: Analysis of the Randomized AMBER Trial Kidney360, 2021-03-25 DOI, PubMed 35369022, PMC8785994 Not in the PMC Open Access subset.
  • Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial Lancet (London, England), 2019-10-26 DOI, PubMed 31533906

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Bulgaria, Croatia, Georgia, Germany, Hungary, South Africa, Ukraine, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03071263. Randomized; quadruple masking; primary purpose treatment. Start 2017-01-23 (actual); primary completion 2018-11-27 (actual). Results posted on 2020-01-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
Acronym
AMBER
Condition
Hyperkalemia
Condition
Resistant Hypertension
Intervention (Drug)
Patiromer
Intervention (Drug)
Placebo
Intervention (Drug)
Spironolactone
Lead sponsor
Relypsa, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03071263
Content hash
fed3e2147a11a8f18a7199b7271d2be8ec78f2245f697792582f7aea2c3ceb2f